Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine-Reference-Cited by-同舟云学术

Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine

Published:2012-02 Issue:2 Volume:31 Page:124-128
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

de Sevilla Maria F.,García-García Juan-José,Esteva Cristina,Moraga Fernando,Hernández Sergi,Selva Laura,Coll Francisco,Ciruela Pilar,Planes Ana Maria,Codina Gemma,Salleras Luis,Jordan Iolanda,Domínguez Angela,Muñoz-Almagro Carmen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference25 articles.

1. . Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.;OBrien;Lancet,2009

2. . Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part 1.;Hausdorff;Clin Infect Dis,2000

3. . Postlicensure surveillance for pneumococcal disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.;Black;Pediatr Infect Dis J,2004

4. . Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.;Whitney;N Engl J Med,2003

5. . Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of 7-valent conjugate vaccine.;Munoz-Almagro;Clin Infect Dis,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13;Microbiology Spectrum;2021-12-22

2. Enfermedad neumocócica invasiva en niños menores de 60 meses, antes y después de la introducción de la vacuna conjugada 13-valente;Anales de Pediatría;2021-07

3. Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccine;Anales de Pediatría (English Edition);2021-07

4. Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease;Vaccines;2021-06-02

5. Epidemiological, Clinical, and Microbiological Characteristics of Serotype-3 Streptoccocus pneumoniae Infection after a Partial Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Prospective Observational Study;Journal of Pediatric Infectious Diseases;2020-03-02